News for 'Safety Research'

How complex is the process of getting approval for a vaccine?

How complex is the process of getting approval for a vaccine?

Rediff.com30 Sep 2020

Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through this carefully drawn journey of vaccine development.

Russia's COVID vaccine shows over 91% efficacy in phase 3 trial

Russia's COVID vaccine shows over 91% efficacy in phase 3 trial

Rediff.com2 Feb 2021

The Gam-COVID-Vac, called Sputnik V, is a two-part vaccine that includes two adenovirus vectors -- recombinant human adenovirus type 26 (rAd26-S) and recombinant human adenovirus type 5 (rAd5-S).

India likely to have Covid vaccine in new year: DCGI

India likely to have Covid vaccine in new year: DCGI

Rediff.com31 Dec 2020

The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.

Cong leaders raise concern over emergency vaccine nod

Cong leaders raise concern over emergency vaccine nod

Rediff.com4 Jan 2021

Senior Congress leader Anand Sharma on Sunday raised concerns over India's drugs regulator granting permission for restricted use of Bharat Biotech's COVID-19 vaccine and asked the government to explain why mandatory protocols and verification of data has been dispensed with.

10 Things To Check Before You Swipe Right

10 Things To Check Before You Swipe Right

Rediff.com16 Sep 2022

If you are looking for a real relationship, physical proximity is critical.

ICMR, Hyderabad co develop potential treatment for COVID-19

ICMR, Hyderabad co develop potential treatment for COVID-19

Rediff.com2 Oct 2020

'The ICMR and Biological E Limited, Hyderabad, have developed highly purified antisera (raised in animals) for prophylaxis and treatment of COVID-19,' the apex health research body said on Thursday. The 'antisera' is yet to undergo human clinical trials to establish its safety and efficacy and Drugs Controller General of India would be approached soon in this regard, Dr Samiran Panda, the head of epidemiology and communicable diseases at the ICMR said.

Vaccine trials: Bharat Biotech recruits 23,000 volunteers

Vaccine trials: Bharat Biotech recruits 23,000 volunteers

Rediff.com3 Jan 2021

Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV). The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the country's first and only Phase III efficacy study for a COVID-19 vaccine, a press release from the vaccine maker said on Saturday night.

Just Chillin! Bear Enjoys Ice Bath

Just Chillin! Bear Enjoys Ice Bath

Rediff.com16 Jul 2021

The Best Videos of the Week.

Don't mince words, say Coronil is not a cure for Covid, HC tells Ramdev

Don't mince words, say Coronil is not a cure for Covid, HC tells Ramdev

Rediff.com4 Aug 2022

Justice Anup Jairam Bhambhani said that he was not "comfortable" with the present draft clarification given by the yoga guru, remarking that it seemed "more like a pat on the back" and a justification.

First volunteer given COVID-19 vaccine in UK

First volunteer given COVID-19 vaccine in UK

Rediff.com24 Jun 2020

If the vaccine is safe and shows a promising immune response in humans, then larger trials would be planned for later in the year.

'Shivaji eclipsed even the Gods'

'Shivaji eclipsed even the Gods'

Rediff.com27 Oct 2022

'We need to be proud of our Maratha history and should be ready to tell the world our stories and not just keep them limited to Maharashtra.'

DCGI nod to Phase-1 trials of potential COVID-19 treatment 'antisera'

DCGI nod to Phase-1 trials of potential COVID-19 treatment 'antisera'

Rediff.com6 Oct 2020

The 'antisera' has been developed by the ICMR in collaboration with a Hyderabad-based bio-pharmaceutical firm. "With Biological E Limited we have developed an horse 'antisera' and we have just got clearance for conducting clinical trials for that," ICMR Director General Dr Balram Bhargava said at press briefing.

50% Indians hide online activity from parents

50% Indians hide online activity from parents

Rediff.com28 Oct 2020

Almost 50% of young Internet users did not have any parental oversight over their online behaviour.

US gives full approval to Pfizer Covid vaccine

US gives full approval to Pfizer Covid vaccine

Rediff.com23 Aug 2021

More than 200 million Pfizer doses have been administered in the US, and hundreds of millions more worldwide, since December.

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Rediff.com19 Aug 2020

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year.

Coronavirus: What about the Lab in Wuhan?

Coronavirus: What about the Lab in Wuhan?

Rediff.com12 Apr 2020

Why did the Chinese military take over the lab in Wuhan in end January? Did something go wrong? Claude Arpi glances at the mystery surrounding the origin of the coronavirus.

Why Young Investors Love Smallcases

Why Young Investors Love Smallcases

Rediff.com27 Sep 2021

Affordable pricing, a variety of themes, and the ease of transacting are among key reasons that have made smallcases a hit among young investors.

India approves Oxford's, Bharat Biotech's vaccines for emergency use

India approves Oxford's, Bharat Biotech's vaccines for emergency use

Rediff.com3 Jan 2021

The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

Rediff.com14 Jun 2021

In the trial, the vaccine will be given by the intramuscular route in two doses on day 0 and day 28.

Codes give more power to states to be flexible on labour laws

Codes give more power to states to be flexible on labour laws

Rediff.com3 Oct 2020

The move will help industries in pushing authorities for exemption under various labour laws at a micro-level, along with demanding changes to bring greater flexibility in their operations related to retrenchment, safety standards, and collective bargaining.

 Covaxin shows robust response

Covaxin shows robust response

Rediff.com17 Dec 2020

Bharat Biotech is in the middle of conducting a phase 3 trial with 22,000 subjects.

Why Vaughan is against banning bouncers for U-18 players

Why Vaughan is against banning bouncers for U-18 players

Rediff.com28 Jan 2021

However, Vaughan did not find any merit in the suggestion.

CAs scramble to fathom new whistleblowing law

CAs scramble to fathom new whistleblowing law

Rediff.com2 Nov 2021

Chartered accountants are readying themselves for a higher onus on individuals to report violations that they come across as part of their work. There has been a scramble to understand the implications as the non-compliance with laws and regulations (NOCLAR) comes into effect in less than six months. It is applicable from April 1, 2022 after being deferred earlier because of the Covid-19 pandemic.

Clinical trials of COVID-19 vaccine show promising early results: Experts

Clinical trials of COVID-19 vaccine show promising early results: Experts

Rediff.com21 May 2020

Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.

Sputnik V vaccine may be added to India's Covid armoury soon

Sputnik V vaccine may be added to India's Covid armoury soon

Rediff.com30 Mar 2021

'We expect to get the approval in the next few weeks,' says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL).

Buying a New Car? An 8-point Check-List

Buying a New Car? An 8-point Check-List

Rediff.com10 Jun 2021

Is it only about choosing the right model and manufacturer? No, there's more to it. Know how to select the ideal car.

'Even if authorised, missile firing makes no sense'

'Even if authorised, missile firing makes no sense'

Rediff.com13 Mar 2022

'This cannot be credibly explained away by referring to a "technical glitch".'

'Vaccine is far safer than getting Covid'

'Vaccine is far safer than getting Covid'

Rediff.com16 Jan 2021

'I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment since at least 11,500 have got at least one dose by now and it has proven to be safe.'

'This looks more like a terror attack'

'This looks more like a terror attack'

Rediff.com2 Dec 2022

'They (the ransomware attackers) are not after any VVIP data.' 'Had that been the case, they would have quietly installed a different malware.'

DRDO carries out successful test firing of surface-to-air missile

DRDO carries out successful test firing of surface-to-air missile

Rediff.com8 Dec 2021

The quick reaction surface-to-air-missile missile developed by DRDO was test launched from the Integrated Test Range at Chandipur near here at about 3.08 pm from a vertical launcher against an electronic target at a very low altitude.

Serum Institute ready to roll out Covid vaccine

Serum Institute ready to roll out Covid vaccine

Rediff.com3 Jan 2021

The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.

Rediff Chat: All your questions on coronavirus answered

Rediff Chat: All your questions on coronavirus answered

Rediff.com29 Mar 2020

Join infectious disease specialist Dr Trupti Gilada on Rediff Chat and have all your queries on coronavirus answered.

Japan or Environment: What is US priority?

Japan or Environment: What is US priority?

Rediff.com31 Jul 2021

Bibhu Prasad Routray explains why the US is supporting Japan's resolve to release 'treated' radioactive waste water into the Pacific Ocean. And what role China plays in the US decision.

COVID-19: India reports 23,950 new cases

COVID-19: India reports 23,950 new cases

Rediff.com23 Dec 2020

There are 2,89,240 active cases of coronavirus infections in the country which comprises 2.86 per cent of the total caseload.

Indian Railways to get special track for high-speed trials

Indian Railways to get special track for high-speed trials

Rediff.com7 Nov 2018

As the national transporter is planning to come out with semi-high speed routes where trains can clock an average speed of 160-200 kmph, dedicated testing becomes essential.

UK's new antibody treatment against Covid may work against Omicron

UK's new antibody treatment against Covid may work against Omicron

Rediff.com2 Dec 2021

The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron.

Flyers subject to random sampling can leave after giving samples: Govt

Flyers subject to random sampling can leave after giving samples: Govt

Rediff.com1 Dec 2021

The ministry of civil aviation on Wednesday said only two per cent of the passengers coming from countries that are not in the 'at-risk' list will be subject to random sampling for coronavirus and such passengers will be permitted to leave the airport after giving the samples.

Kashmiris who cheered for Pak team charged with sedition, sent to jail

Kashmiris who cheered for Pak team charged with sedition, sent to jail

Rediff.com29 Oct 2021

The three students, two of them aged 20 and one 21, were also remanded in 14-day judicial custody by an Agra court, the officials said.

Will India's Covaxin be world's first COVID-19 drug?

Will India's Covaxin be world's first COVID-19 drug?

Rediff.com3 Jul 2020

'We need to prove to the world that quality vaccines and R&D are possible in India.'

Bharat Biotech seeks emergency nod for use of Covaxin

Bharat Biotech seeks emergency nod for use of Covaxin

Rediff.com8 Dec 2020

Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).